MS analysis of these synthesized crosslinked peptide standards supports the identification of S262-C291 and S400-C291 DHAA-XLs in Tau, as the observed intact masses and isotopic distributions, as well as the observed fragmentation patterns in MS2 spectra, all match those of the identified crosslinked species in the AD brain specimens. The gene discussed is MAPT; the disease is Alzheimer disease.